Blog
RSS FeedPosted by Michael Wonder on 24 Sep 2019
Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices
23 September 2019 - A group of institutional investors representing more than US$500 billion is calling on the U.S. Congress ...
Posted by Michael Wonder on 10 Sep 2019
Canada releases final amendments to patented medicines pricing regulations
9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...
Posted by Michael Wonder on 08 Sep 2019
Trudeau’s drug price overhaul is set to cost drug makers billions
6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...
Posted by Michael Wonder on 26 Aug 2019
Drug-price reforms need not affect research on rare diseases – or the Canadians who have them
26 August 2019 - On 9 August, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for ...
Posted by Michael Wonder on 24 Aug 2019
Companies file suit in Canada challenging new rules to lower drug prices
23 August 2019 - Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging ...
Posted by Michael Wonder on 21 Aug 2019
Empirical evidence supports critics of Patented Medicine Prices Review Board regulations
21 August 2019 - Canadian Health Policy Institute, a Toronto-based private-sector think-tank established in 2012, has published several studies that bolster ...
Posted by Michael Wonder on 18 Aug 2019
Bring in pharmacare now, health experts ask federal leaders
15 August 2019 - Signatories include professors of medicine, pharmacy, nursing, economics, political science and law. ...
Posted by Michael Wonder on 16 Aug 2019
What will PMPRB drug pricing changes mean for plan sponsors?
15 August 2019 - Private plan sponsors can expect to see lower drug prices resulting from recent changes to the ...
Posted by Michael Wonder on 14 Aug 2019
Canadians benefitting from substantially lower generic drug prices
14 August 2019 - Latest agreement between public payers and the Canadian generic industry closes gap with international prices. ...
Posted by Michael Wonder on 13 Aug 2019
Ottawa’s move to cut drug prices may lead to fewer new launches, less R&D
13 August 2019 - Health Canada is fundamentally changing how prescription drugs are priced in Canada. ...
Posted by Michael Wonder on 13 Aug 2019
Proposed new drug regulations will hurt all Canadians — and Ottawa has been warned
13 August 2019 - Changes which aim to make prescriptions more affordable could shut off entry of new drugs. ...
Posted by Michael Wonder on 13 Aug 2019
Canadian drug price regulator may be flexible on rare diseases
14 August 2019 - Canada’s patented drug price regulator, set to gain new powers next year, may be “more forgiving” in ...
Posted by Michael Wonder on 12 Aug 2019
Federal changes to drug prices win praise from patient advocates but spark industry warnings
10 August 2019 - A federal government move to lower drug prices is winning praise from some patient advocates but ...
Posted by Michael Wonder on 11 Aug 2019
Drug policy experts accuse industry and patient groups of 'fearmongering' with concerns about new drug pricing rule
11 August 2019 - Industry groups and patient advocates are raising concerns about the federal government’s new drug-pricing rules, claiming ...
Posted by Michael Wonder on 11 Aug 2019
Details of Canada's biggest drug pricing overhaul in decades
10 August 2019 - The Canadian government finalized the biggest overhaul to its drug pricing regime since 1987 on Friday, ...